Jonathan M. Flanagan

Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia

Russell E. Ware, Jenny M. Despotovic, Nicole A. Mortier et al. · Blood · 2011 · 168 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Characterization of Cytoplasmic Caspase-2 Activation by Induced Proximity

Lisa Bouchier‐Hayes, Andrew Oberst, Gavin P. McStay et al. · Molecular Cell · 2009 · 154 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population

Michael D. Kessler, Douglas P. Loesch, James A. Perry et al. · Proceedings of the National Academy of Sciences · 2020 · 112 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Organ-on-chips made of blood: endothelial progenitor cells from blood reconstitute vascular thromboinflammation in vessel-chips

Tanmay Mathur, Kanwar Abhay Singh, Navaneeth Krishna Rajeeva Pandian et al. · Lab on a Chip · 2019 · 93 citations · Full text

Engineering, Bioengineering, Cell Biology +17

Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes

Vivien Sheehan, Zhaoyu Luo, Jonathan M. Flanagan et al. · American Journal of Hematology · 2013 · 88 citations

Medicine, Genetics, Hematology +16